Synaptic Plasticity and the Dynamic Interactions Between Calcium and Presynaptic

描述(申请人提供)：了解突触的功能是了解神经系统的关键，然而，尽管突触的传递普遍由突触前G蛋白偶联受体(GPCRs)控制，但这些受体调节释放的方式仍存在争议。中枢神经疾病是通过药物干预来治疗gpr功能的，包括攻击性、抑郁症和精神分裂症。抑制性突触前GPCRs通过多种机制改变突触功能。这些可以利用G？G蛋白亚基调节突触前离子通道，然后调节突触分泌，或者调节囊泡融合的机制，即SNARE复合体。或者，这些信令系统可以通过其他第二信使间接地起作用。我们关注的是G？？通过哪些直接机制？？抑制递质释放，并已证明G？？可以通过与融合机制-圈套复合体的相互作用来抑制神经分泌。这种相互作用发生在突触激活的后期，在启动后，囊泡中形成了圈套复合体。我们假设G？与三元SNARE复合体结合，与钙离子依赖的突触素结合竞争。这样，G？可能被认为是干扰导致神经分泌的最后开关的手段。我们建议G？？的这一行动。由于突触前的高钙浓度使突触聚集素能够更有效地与囊泡融合机制竞争，也使突触前抑制对G？？介导的突触前抑制具有钙依赖性。这场比赛的最终结果是什么？？与突触素的竞争允许对分泌进行微调控制。G？导致出胞性小泡的接吻和逃逸融合。这降低了神经递质的突触峰值浓度，为GPCRs改变突触功能的方法增加了一个复杂的转折。我们建议研究激活突触的开关--钙离子--突触聚集蛋白--和这一过程的抑制因子--G？之间的竞争。我们假设G？和synaptopagmin在SNARE复合体上共享一个相互作用的部位。为了证明这一点，我们将调查G？？在SNARE复合体中与突触素竞争，并将钙离子对这种竞争的影响与在简单的重组融合模型中的类似操作以及在七鳃鳗巨轴突的原位操作进行比较。然后，我们将使用细胞内应用的肉毒杆菌毒素对原位SNARE复合蛋白进行修饰，以比较体外类似的截断。我们还将使用外源应用G？？的荧光测量。建立囊泡融合蛋白质组分的模型系统，以确定钙离子是否对结合和原位神经递质释放产生类似的影响。然后，这些实验范例将通过动态波动的钙离子浓度来复制，以模拟真实世界中中央突触的活动。这些实验将使我们深入了解简单的蛋白质-蛋白质相互作用所可能的动态调节，并解释突触前GPCR介导的突触前调节的一些复杂性及其在神经病理学中的作用。 公共卫生相关性：在中枢神经系统中，G蛋白偶联受体无处不在，与这组广泛分布的受体功能障碍相关的病理会导致毁灭性的精神疾病，包括帕金森氏症、精神分裂症、抑郁症和强迫症。然而，在神经系统交流的基本单元--突触--我们对G蛋白的功能知之甚少。我们希望了解这些机制是如何使用这样的受体5-HT1B受体作为简单脊椎动物突触的模型来改变化学通讯的。我们将确定这种受体是如何起作用的，以及它如何调节整个大脑的化学交流。

DESCRIPTION (provided by applicant): Understanding the function of synapses is key to understanding the nervous system, and yet, while synaptic transmission is ubiquitously controlled by presynaptic G protein coupled receptors (GPCRs), the means by which these receptors modify release is contentious. Central nervous diseases, in which GPCR function is treated by pharmacological intervention, cover conditions ranging from aggression, depression and schizophrenia. Inhibitory presynaptic GPCRs alter synaptic function by many mechanisms. These may utilize the G?? G protein subunit to modify presynaptic ion channels and then synaptic secretion, or to modify the very machinery of vesicle fusion, the SNARE complex. Alternatively, these signaling systems may act indirectly through, other second messengers. We have focused on direct mechanisms by which G?? inhibits transmitter release and have demonstrated that G?? can inhibit neurosecretion by an interaction with the fusion machinery - the SNARE complex. This interaction occurs late in the activation of the synapse, after priming, in vesicles whose SNARE complex is formed. We hypothesize that G?? binds to the ternary SNARE complex to compete with Ca2+-dependent synaptotagmin binding. In this way G?? might be thought of as means to interfere with the final switch leading to neurosecretion. We propose that this action of G?? also confers a Ca2+ dependency on G?? -mediated presynaptic inhibition because high presynaptic Ca2+ concentrations allow synaptotagmin to compete more effectively with the machinery of vesicle fusion. The final outcome of this G?? competition with synaptotagmin allows a fine-tuned control of secretion. G?? causes kiss-and-run fusion of the exocytosing vesicle. This reduces the peak synaptic concentration of neurotransmitter, adding a complex twist to the method by which GPCRs alter synaptic function. We propose to investigate competition between the switch that activates synapses - Ca2+-synaptotagmin - and an inhibitor of this process - G??. We hypothesize that G?? and synaptotagmin share an interaction site on the SNARE complex. To demonstrate this, we will investigate G?? competition with synaptotagmin at the SNARE complex and compare effects of Ca2+ on this competition to similar manipulations in a simple reconstituted model for fusion and at the lamprey giant axon in situ. We will then modify in situ SNARE complex proteins using intracellularly applied Botulinum toxins to compare similar truncations in vitro. We will also use fluorescence measurements of exogenously applied G?? model systems of the protein components of vesicle fusion to determine whether Ca2+ evokes similar effects on binding and on neurotransmitter release in situ. These experimental paradigms will then be reproduced with dynamically fluctuating Ca2+ concentrations to mimic a real world activity of central synapses. These experiments will afford insight into the dynamic modulation possible with a simple protein-protein interaction and explain some of the complexities of presynaptic GPCR-mediated presynaptic modulation and their roles in neuropathologies. PUBLIC HEALTH RELEVANCE: In the central nervous system, G protein coupled receptors are ubiquitous and pathologies related to dysfunction of this widely distributed group of receptors lead to devastating illnesses of the mind, including Parkinson's disease, Schizoprenia, depression and compulsive disorders. However, at the basic unit of nervous system communication - the synapse - we understand little of the way G proteins function. We wish to understand how these mechanisms modify chemical communication using one such receptor, the 5-HT1B receptor, as a model in a simple vertebrate synapse. We will determine how this receptor acts and how it modulates chemical communication throughout the brain.